Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
- DOI
- 10.1016/j.ebiom.2021.103255
- Published
- 2021 Mar
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2021.103255,
title = {Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.},
author = {Hoffmann M and Hofmann-Winkler H and Smith JC and Krüger N and Arora P and Sørensen LK and Søgaard OS and Hasselstrøm JB and Winkler M and Hempel T and Raich L and Olsson S and Danov O and Jonigk D and Yamazoe T and Yamatsuta K and Mizuno H and Ludwig S and Noé F and Kjolby M and Braun A and Sheltzer JM and Pöhlmann S},
year = {2021},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2021.103255},
url = {https://doi.org/10.1016/j.ebiom.2021.103255}
}RIS
TY - JOUR TI - Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. AU - Hoffmann M AU - Hofmann-Winkler H AU - Smith JC AU - Krüger N AU - Arora P AU - Sørensen LK AU - Søgaard OS AU - Hasselstrøm JB AU - Winkler M AU - Hempel T AU - Raich L AU - Olsson S AU - Danov O AU - Jonigk D AU - Yamazoe T AU - Yamatsuta K AU - Mizuno H AU - Ludwig S AU - Noé F AU - Kjolby M AU - Braun A AU - Sheltzer JM AU - Pöhlmann S PY - 2021 JO - EBioMedicine DO - 10.1016/j.ebiom.2021.103255 UR - https://doi.org/10.1016/j.ebiom.2021.103255 ER -
APA
M, H., H, H., JC, S., N, K., P, A., LK, S., OS, S., JB, H., M, W., T, H., L, R., S, O., O, D., D, J., T, Y., K, Y., H, M., S, L., F, N., M, K., A, B., JM, S., & S, P. (2021). Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2021.103255
Source records
- pubmed · retrieved 2026-11-10T20:10:33.493Z